Guideline for 5-alpha-reductase inhibitors in the prevention of prostate cancer is premature.
Frankel
Paul H
PH
Twardowski
Przemyslaw
P
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D042944:Cholestenone 5 alpha-Reductase / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000517:prevention & control*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D018120:Finasteride; D042944:Cholestenone 5 alpha-Reductase